| Literature DB >> 35372266 |
Xiuzhao Yin1,2, Fujin Ai2, Linbo Han2.
Abstract
Metal-organic frameworks (MOFs) are 3D-architecture compounds of metal ions and organic molecules with sufficient and permanent porosity, showing great potential as a versatile platform to load various functional moieties to endow the hybrid materials with specific applications. Currently, a variety of photothermal nanometals have been embedded into organic ligands for integrating the unique photothermal effects with the merits of MOFs to improve their performances for cancer therapy. In this review, we have summarized a series of novel MOF-based photothermal materials for this unique therapeutic modality against tumors from three main aspects according to their chemical compositions and structures, i) metal-doped MOF, ii) organic-doped MOF, and iii) polymer-coated MOF. In addition, we have summarized the latest developments and characteristics of MOF-based photothermal agents, such as good biocompatibility, low toxicity, and responsive photothermal conversion without destroying the structure of hybrid photothermal agent. At last, we addressed the future perspectives of MOF-based photothermal agent in the field of phototherapy.Entities:
Keywords: MOFs; ablation; phototherapy; photothermal agent; therapeutic modality
Year: 2022 PMID: 35372266 PMCID: PMC8966584 DOI: 10.3389/fchem.2022.841316
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.221
Summary of MOFs used as photothermal theranostic platforms
| MOFs | MOF skeleton components | Therapeutic option | Animal model | References |
|---|---|---|---|---|
| AU@MOF-DOX | Zn2+, 2-H-MeIM | Chemotherapy, PTT | H22 Tumor-bearing mice | ( |
| MGH | Fe3+, BTC | CDT, PT, starvation therapy | 4T1 Tumor-bearing mice | ( |
| HUC- PEG | Hf4+, BDC, TCPC | PTT, PDT | U14 Tumor-bearing mice | ( |
| LA-AUNR/ZIF-8 | Zn2+, 2-H-MeIM | Chemotherapy, PTT | H22 Tumor-bearing mice | ( |
| B9-MIL@cat-fML | Fe3+, NH2-BDC | PTT, PDT | HeLa Tumor-bearing mice | ( |
| Cu-TCPP MOF | 4-carboxyphenyl, porphyrin | PTT, PDT | Saos-2 Tumor-bearing mice | ( |
| Cu@MOF | PCN 224 | Chemotherapy, PTT | NIH3T3 Tumor-bearing mice | ( |
| siRNA/Zr- FeP MOF | Zr-FeP | PTT, PDT | MCF-7Tumor-bearing mice | ( |
| PPY@MOF | MTT | PTT | 4T1 Tumor-bearing mice | ( |
| PDA@MOF | Zn2+, 2-H-MeIM | Chemotherapy, PTT | 4T1 Tumor-bearing mice | ( |
The advantages and disadvantages of the three categories
| MOFs | Advantages | Disadvantages |
|---|---|---|
| Metal-doped MOF | PTA/MOF materials with designed functionalities, such as fluorescence imaging, chemo-photothermal therapy and controlled drug release | Low yield of nanoparticles, low biocompatibility |
| Organic-doped MOF | Low toxicity, magnetic resonance (MR) imaging capability, PDT therapy, controlled drug release, superior photothermal conversion efficiency | Connection between MOF structure and treatment efficiency, chronic toxicity assessment caused by acute toxicity and molecular level |
| Polymer-coated MOF | Good stability, biocompatibility and degradation performance, stimulus-response multifunctional abilities, chemo-photothermal therapy | Low yield of nanoparticles, redirection of drug release |
FIGURE 1(A) Schematic representation of the Au NRs@ZIF-8 core–shell nanostructures. (B) TEM image of CTAB-stabilized Au NRs and HAADF-STEM image of single Au NRs@ZIF-8 core shell nanostructure. (C) The temperature increased by Au NRs@ZIF-8 core–shell nanostructures in PBS solution l. (D,E) Observation of changes in (D) body weight and (E) relative tumor volume from 4T1 tumor-bearing mice with different treatments. Reproduced with permission (Li et al., 2018). Copyright 2018, Nano Research.
FIGURE 2(A) Heating and cooling circles for Au@MOF. (B) The photothermal performance of the Au@MOF with different concentrations of Au irradiated. (C) The temperature increasing and cooling curves of Au@MOF aqueous solution with concentration fixed on 50 ppm Au. (D–F) are measured under the 1,064 nm laser irradiation, (A–C) are measured under the 808 nm laser irradiation. Reproduced with permission (Deng et al., 2019). Copyright 2019, Nano Letters.
FIGURE 3(A) Photothermal imaging in mice and (B) The temperature rise before and after injection of MOF-Fe nanomaterials. (C) The emission spectrum of NaGdF4:Yb,Tm@NaGdF4:Yb and shell of iron ions. (D) Schematic diagram of the role of iron ions. (E) Confocal image of HeLa cells with different treatment (UCNPs@MIL-100[Fe] NPs and control). (F) The weight of mice are treated differently. (G) The changes in tumor volume are treated differently. (H) Photos of the changes in the body weight and (I) tumor volume of mice. (J) Physical photos of mice after different treatments with control, pure DOX, and UCNPs@MIL-100(Fe) NPs. Reproduced with permission (Yang et al., 2018) Copyright 2018, Chemical Engineering Journal.
FIGURE 4(A) UV absorption curve of copper nanosheet MOF. (B) Cu 2p XPS spectrum for copper nanosheet MOF. (C) Heating curve of different concentrations of copper nanosheet MOF. (D) Temperature change curve of different concentrations of MOF material. (E) The light-heat curve of mice with light time. (F) Change of heating curve before and after adding MOFs. (G) Changes in tumor volume in mice after receiving different treatments. (H) Picture of changes in mouse tumor volume after different treatments. 1: PBS; 2: Cu nanosheet; 3: PBS + Laser; 4: Cu nanosheet + PDT; 5: Cu nanosheet + PTT; 6: Cu nanosheet + Laser. Reproduced with permission (Li et al., 2019b). Copyright 2018, Theranostics.
FIGURE 5(A) Schematic diagram of the preparation of copper MOF material. (B) TEM images. (C) Heating and cooling curves of copper MOF materials under light. (D) Light and heat curves of MOF materials with different copper content, Cu5MOF, Cu10MOF, and Cu15MOF, Cu25MOF. (E) Schematic diagram of the mechanism of copper MOF material improving photocatalysis and photothermal effect. Reproduced with permission (Han et al., 2020). Copyright 2020, Applied Catalysis B: Environmental.
FIGURE 6Synthetic schematic diagram of Zr-PDI. (A) Schematic diagram of the special structure of Zr and P-2COOH. (B) The connection method of Zr and P-2COOH. (C) a-Axis crystal structure of Zr-PDI. (D) The microstructure of Zr-PDI. (E) Light and heat stability curve of Zr-PDI. (F) Nitrogen adsorption curve of Zr-PD and pore size distribution. (G) Schematic diagram of photothermal conversion of Zr-PD. (H) Photothermal conversion curves of Zr-PDI•− film on quartz glass. (I) Heating and cooling curves of Zr-PD at different optical powers. (J) Light and heat stability curve of Zr-PDI. (K) Photothermal digital picture of Zr-PDI-BUCT. Reproduced with permission (Lü et al., 2019). Copyright 2019, Nature Communication.
FIGURE 7(A) Schematic diagram of Fe-soc-MOF@PPy composite material synthesis; (B) 808 nm Laser for PTT. (C) Different concentration of Fe-soc-MOF@PPy heating curve. (D) Fe-soc-MOF@PPy heating and cooling curve. (E) The body weight change curve of mice after different treatments. (F) Tumor volume change curve after different treatments in mice, respectively. Reproduced with permission (Xuechao et al., 2019). Copyright 2019, Chemical Engineering Journal.
FIGURE 8(A) Schematic MOFs as combinational therapy. (B) Heating curve of different concentrations of sgc-8-PDA-DOX/ZIF-8. (C) Heating curve of various components of PDA-DOX/ZIF-8. (D) Viability of HeLa cells with various concentrations of PDA–DOX/ZIF-8 and sgc-8–PDA–DOX/ZIF-8 in the presence or absence of 808 nm irradiation. (E) The change curve of tumor volume in mice after different treatments. Reproduced with permission (Feng et al., 2019). Copyright 2019, J. Mater. Chem. B.